Shree Ganesh Remedies

Shree Ganesh Remedies

464.00
+2.30
(0.50%)
hide
Key Fundamentals
Add Ratio
Market Cap
592.70 Cr
EPS
17.96
PE Ratio
29.00
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
950.00
52 Week Low
452.20
PB Ratio
3.86
Debt to Equity
0.28
Forecast For
Actual

Company News

View All News
Caret
neutral
Shree Ganesh Remedies Reports Board Meeting Outcomes and Independent Director Resignation5 days ago
Shree Ganesh Remedies Limited announced the outcomes of its Board meeting held on November 7, 2025. The Board approved unaudited financial results for the quarter and half-year ended September 30, 2025, along with limited review reports from auditors. The company also announced the resignation of Mr. Priyam Surendra Shah as Independent Director with immediate effect due to pre-occupation. Shah confirmed there are no material reasons for his resignation other than those mentioned in his resignation letter. The company's consolidated results include its wholly owned subsidiary SGR USA Inc. The financial results were prepared in accordance with Indian Accounting Standards and reviewed by the Audit Committee before Board approval.
positive
Shree Ganesh Remedies Limited's Board of Directors appointed Ms. Shruti Sohane as Additional Director (Non-Executive, Independent) for a five-year term effective August 08, 2025, subject to shareholder approval. Ms. Sohane is a qualified Company Secretary with over a decade of experience in corporate governance and legal compliance, and is a member of the Institute of Company Secretaries of India since 2014. The company also reappointed M/s. M. I. Prajapati & Associates as Cost Auditor for 2025-2026 at a remuneration of Rs. 55,000 plus applicable taxes. Additionally, the Board appointed Mr. Vishal Thawani as Scrutinizer for the e-voting process at the 30th Annual General Meeting and approved the Notice for the AGM along with the Directors Report for the year ended March 31, 2025.
neutral
Shree Ganesh Remedies Reports Q1 FY2026 Financial Results with Profit GrowthAug 01, 2025
Shree Ganesh Remedies Limited's Board approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2025. The company reported consolidated revenue from operations of ₹2,466.79 lakhs compared to ₹2,477.99 lakhs in the same quarter last year. Profit after tax increased to ₹344.51 lakhs from ₹464.88 lakhs in the previous year quarter. Basic earnings per share stood at ₹2.68 compared to ₹3.62 in the corresponding quarter. On standalone basis, the company achieved profit after tax of ₹344.94 lakhs with basic EPS of ₹2.69. The company operates primarily in bulk drug intermediates business and has a wholly owned subsidiary SGRL USA INC. Total comprehensive income for the quarter was ₹344.16 lakhs on consolidated basis.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,732.10
#1 4,11,749.90
39.63
#1 54,729.00
9.71
#1 10,980
2.89
66.26
6,520.00
1,73,603.20
69.64
9,712.00
18.67
2,191
35.10
50.59
3,824.60
1,29,482.50
60.46
11,539.40
6.99
1,911
30.46
70.50
1,519.30
1,22,366.70
22.59
28,409.50
7.12
5,291
3.71
44.46
1,229.60
1,01,113.50
#1 17.88
33,741.20
16.73
5,725
-0.38
47.35
951.40
94,475.30
19.03
23,511.00
18.55
4,615
34.60
39.39
2,270.00
91,653.00
52.89
12,744.20
#1 20.90
2,007
-21.05
32.59
2,033.90
90,250.10
21.39
22,909.50
13.74
3,306
#1 72.75
62.84
5,767.50
68,110.20
29.54
13,458.30
3.70
2,216
21.39
70.49
1,183.60
67,849.20
20.35
32,345.60
9.43
3,484
3.81
67.18
Growth Rate
Revenue Growth
-12.95 %
Net Income Growth
-17.79 %
Cash Flow Change
0.69 %
ROE
-30.97 %
ROCE
-25.41 %
EBITDA Margin (Avg.)
9.86 %

Quarterly Financial Results

Quarterly Financials
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Revenue
10
12
14
16
14
17
22
39
25
33
28
27
25
31
Expenses
8
7
10
10
10
13
15
20
17
21
17
15
17
21
EBITDA
2
5
4
5
4
5
7
18
9
12
11
12
8
10
Operating Profit %
12 %
36 %
24 %
33 %
24 %
26 %
27 %
45 %
33 %
35 %
37 %
40 %
30 %
32 %
Depreciation
1
1
0
1
1
1
1
2
2
2
3
2
2
3
Interest
0
0
0
0
0
0
0
0
0
0
0
1
1
1
Profit Before Tax
1
4
4
4
3
4
6
16
6
9
8
9
5
7
Tax
1
1
1
1
1
1
1
4
2
2
2
2
1
2
Net Profit
1
3
3
3
2
3
4
13
5
6
5
7
4
5
EPS in ₹
0.85
6.18
2.31
3.03
4.68
3.02
3.50
10.01
3.62
4.97
4.22
5.13
2.68
3.86

Balance Sheet

Balance Sheet
2019
2020
2024
2025
Total Assets
41
55
171
192
Fixed Assets
15
20
81
95
Current Assets
26
34
70
78
Capital Work in Progress
0
0
17
9
Investments
4
3
5
18
Other Assets
23
32
69
70
Total Liabilities
41
55
171
192
Current Liabilities
7
10
19
16
Non Current Liabilities
1
3
30
31
Total Equity
34
42
122
145
Reserve & Surplus
25
33
109
132
Share Capital
9
9
13
13

Cash Flow

Cash Flow
2019
2020
2024
2025
Net Cash Flow
-6
1
7
-6
Investing Activities
-0
-3
-33
-36
Operating Activities
-5
5
31
31
Financing Activities
-0
-1
10
-1

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Nov 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Feb 2023
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
68.39 %
68.39 %
69.12 %
69.12 %
69.12 %
69.12 %
69.12 %
68.27 %
68.27 %
69.32 %
69.33 %
69.33 %
69.33 %
69.33 %
69.33 %
69.33 %
70.50 %
72.80 %
72.80 %
72.80 %
72.80 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
27.52 %
27.74 %
25.92 %
25.85 %
26.03 %
26.35 %
26.33 %
26.68 %
27.25 %
26.37 %
28.11 %
28.05 %
27.96 %
28.06 %
28.14 %
28.51 %
27.23 %
24.88 %
24.89 %
24.87 %
24.92 %
Others
4.09 %
3.87 %
4.96 %
5.03 %
4.85 %
4.53 %
4.54 %
5.05 %
4.48 %
4.31 %
2.56 %
2.62 %
2.71 %
2.60 %
2.53 %
2.15 %
2.26 %
2.32 %
2.31 %
2.32 %
2.27 %
No of Share Holders
2,450
3,397
4,814
5,828
5,741
5,745
5,465
5,843
6,472
6,771
6,747
6,407
7,330
7,518
7,049
7,186
8,508
8,695
8,978
9,166
8,752

Dividend History

Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 1 1.25 1.5 1.75 0.5 0.3 0.5 0.00
Dividend Yield (%) 0.00 0.00 2.49 2.32 0.54 0.59 0.2 0.04 0.07 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
11 Sept 2021 DIVIDEND Dividend
₹ 1.75 /share
08 Sept 2021 255.80 318.97
02 Nov 2021 BONUS Bonus
1:5
01 Nov 2021 336.47 382.07
16 Sept 2022 DIVIDEND Dividend
₹ 0.50 /share
15 Sept 2022 313.71 251.36
03 Feb 2023 RIGHTS Rights
7:100
03 Feb 2023 256.67 250.56
07 Sept 2023 DIVIDEND Dividend
₹ 0.50 /share
07 Sept 2023 288.45 440.60
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 866.60 822.25
29 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 Oct 2024 767.10 756.85
05 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
05 Feb 2025 669.45 893.20
19 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
19 May 2025 724.45 749.35
01 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
01 Aug 2025 588.25 568.55
09 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
09 Sept 2025 561.25 587.30
07 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Nov 2025 496.00 492.20

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome9 hours ago
Announcement under Regulation 30 (LODR)-Newspaper Publication4 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release5 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation5 days ago
Announcement under Regulation 30 (LODR)-Resignation of Director5 days ago
Financial Results For Quarter And Half Year Ended September 30 20255 days ago
Board Meeting Outcome for Outcome Of Board Meeting5 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation5 days ago
Board Meeting Intimation for The Unaudited Financial Results For The Quarter And Half Year Ended September 30 20259 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 10, 2025
Closure of Trading WindowSep 25, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorSep 15, 2025
Board Meeting Outcome for Outcome Of Board MeetingSep 15, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 09, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 09, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 19, 2025
Notice Of 30Th Annual General Meeting On September 09 2025Aug 18, 2025
Reg. 34 (1) Annual Report.Aug 18, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateAug 08, 2025
Board Meeting Outcome for Outcome Of Board MeetingAug 08, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 02, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 02, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 02, 2025
Board Meeting Outcome for Outcome Of Board MeetingAug 01, 2025
Board Meeting Intimation for Unaudited (Standalone And Consolidated) Financial Results Of The Company For The Quarter Ended On June 30 2025Jul 28, 2025
Announcement Under Regulation 30 Of SEBI Listing Regulations Jul 21, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Closure of Trading WindowJun 26, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 21, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 21, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 19, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 19, 2025
Appointment Of Secretarial Auditors And Internal Auditors Of The CompanyMay 19, 2025
Financial Results March 31 2025May 19, 2025
Board Meeting Outcome for Outcome Of Board MeetingMay 19, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015- Resignation Of Secretarial Auditor.May 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 15, 2025
Board Meeting Intimation for The Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Financial Year Ended On March 31 2025May 10, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 26, 2025
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2Apr 26, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Closure of Trading WindowMar 25, 2025
Commissioning Of 2.5 MW Solar Power Project Mar 25, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 06, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 05, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 05, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan BSE Healthcare Index Fund Direct-Growth
0.01%
0
0.00%
0.01%

Technical Indicators

RSI(14)
Neutral
28.11
ATR(14)
Volatile
17.63
STOCH(9,6)
Neutral
36.75
STOCH RSI(14)
Oversold
14.54
MACD(12,26)
Bearish
-0.81
ADX(14)
Strong Trend
43.81
UO(9)
Bearish
43.61
ROC(12)
Downtrend And Accelerating
-6.84
WillR(14)
Oversold
-82.33